| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70539-400-04 | 70539-400 | HUMAN PRESCRIPTION DRUG | Binosto | alendronate sodium | TABLET, EFFERVESCENT | ORAL | 20120312 | N/A | NDA | NDA202344 | Radius Health, Inc. | ALENDRONATE SODIUM | 91.37 mg/1 | 4 BLISTER PACK in 1 BOX (70539-400-04) / 1 TABLET, EFFERVESCENT in 1 BLISTER PACK (70539-400-00) |
| 70539-400-94 | 70539-400 | HUMAN PRESCRIPTION DRUG | Binosto | alendronate sodium | TABLET, EFFERVESCENT | ORAL | 20230312 | N/A | NDA | NDA202344 | Radius Health, Inc. | ALENDRONATE SODIUM | 91.37 mg/1 | 4 BLISTER PACK in 1 BOX (70539-400-94) / 1 TABLET, EFFERVESCENT in 1 BLISTER PACK (70539-400-00) |
| 17139-400-01 | 17139-400 | HUMAN PRESCRIPTION DRUG | Binosto | alendronate sodium | TABLET, EFFERVESCENT | ORAL | 20191127 | 20250228 | NDA | NDA202344 | ASCEND Therapeutics | ALENDRONATE SODIUM | 70 mg/1 | 1 TABLET, EFFERVESCENT in 1 CARTON (17139-400-01) |
| 17139-400-04 | 17139-400 | HUMAN PRESCRIPTION DRUG | Binosto | alendronate sodium | TABLET, EFFERVESCENT | ORAL | 20191127 | N/A | NDA | NDA202344 | ASCEND Therapeutics | ALENDRONATE SODIUM | 70 mg/1 | 4 TABLET, EFFERVESCENT in 1 CARTON (17139-400-04) |